Association of Antibodies to Heat-Shock Protein-65 with Percutaneous Transluminal Coronary Angioplasty and Subsequent Restenosis

Abstract

SummaryHeat-shock protein (HSP)-65 of mycobacterial origin has been implicated in the mediation of atherosclerosis by immune mechanisms. Any role of HSP-65 in mediating restenosis is however not clear. We determined the anti-HSP-65 antibodies in 28 patients, 25 male and 3 female, aged 35 to 78 years, with coronary artery disease (CAD) and undergoing percutaneous transluminal coronary angioplasty (PTCA). Of the 28 patients, 12 suffered restenosis five to seven months later.The serum levels of antibody were measured at baseline, immediately after PTCA, before discharge from the hospital, and at 6 weeks, 3 and 6 months after the performance of PTCA. The antibody levels were expressed in OD U/log titre, as explained in the text, and termed estimated OD or EOD. The control group consisted of 29 healthy volunteers, 16 male and 13 female, aged 24 to 59 years. The mean Eod of the patients at baseline was higher than that of the controls (0.60 ± 0.12, SD; 95% Cl 0.56-0.64 compared with 0.53 ± 0.13; 0.48-0.58; p < 0.01). There was no correlation between age and EOD of patients, controls or both taken together, ruling out the influence of age on the EOD changes in the given age range. The mean antibody levels of the patients with CAD were similar whether or not they suffered subsequent restenosis (0.61 ± 0.15; 0.53-0.69 in the patency group, and 0.60 ± 0.10; 0.54-0.66 in the restenosis group). However, the patients who did not develop restenosis had a drop in their antibody levels immediately after PTCA (0.51 ± 0.14; 0.48-0.55; 2-tailed p = 0.029), and at discharge from the hospital (0.52 ± 0.15; 0.44-0.60; p = 0.036) as compared with the baseline. This decrease of antibodies was not observed in the restenosis group. Furthermore, the anti-HSP-65 antibody levels remained slightly low throughout the 6-month follow-up in the patients with patent coronaries as compared with patients who reste-nosed, but the decrease was statistically not significant at 5% level at any stage. Besides the anti-HSP-65 antibodies, the levels of anticardio-lipin (ACL) antibody were also measured in all the patients. The levels of the ACL antibody were found to be within the normal range before and at all stages after PTCA, ruling out the PTCA-associated change in the anti-HSP-65 antibody as a non-specific occurrence. Thus, a drop in the level of antibody against HSP-65 after PTCA seemed to be associated with a favourable outcome, and may serve as a useful prognostic marker of coronary angioplasty

Joint Effects of Antibody to Heat Shock Protein 60, Hypertension, and Diabetes on Risk of Coronary Heart Disease in Chinese

“…after angioplasty have been documented in several studies (5,15,(22)(23)(24), but the results are inconsistent (2,(4)(5)(6)(7). Our study is the largest case control study so far on the relationship between anti-Hsp60 and risk of CHD, providing evidence that increasing anti-Hsp60 concentrations are associated with CHD risk in a doseresponsive manner.…”

Association of Serum Antibodies to Heat-Shock Protein 65 With Carotid Atherosclerosis

“…We have previously shown an association of serum antihsp65 antibodies to carotid atherosclerosis, 13 and reports from several groups have demonstrated increased antibody titers in patients with arteriosclerosis or coronary heart diseases, 14,17 which declined after angioplasty or myocardial infarction 15,16 because of immune complex formation, with autologous hsp60 released as a consequence of tissue necrosis. 26a In the present follow-up study, we provide evidence of a sustained elevation of anti-hsp65 antibody titers in subjects with atherosclerosis and demonstrate a predictive value for the progression of atherosclerotic lesions with high risk of mortality.…”

Plasma Concentration of Heat Shock Protein 27 and Risk of Cardiovascular Disease: A Prospective, Nested Case-Control Study

“…Correlations have been reported between several of these factors and cardiovascular risk factors, such as LDL cholesterol and hypertension, and psychosocial measures, such as socioeconomic status and psychological stress (11)(12)(13). Furthermore, several of these factors have been associated with carotid disease and ischemic stroke (11,14,15 ), presence and severity of coronary atherosclerosis (16,17 ), and restenosis after percutaneous transluminal coronary angio- plasty (18 ). They have also been associated with aortic disease and peripheral vascular disease (19 -21 ).…”